Listeria Meningitis After Infliximab in Ulcerative Colitis: Does the Risk of Treatment Outweigh the Benefit
Iyad A Issa & Ali Eid · Journal of Advances in Medicine and Medical Research · 2013
Biologic agents have become important treatment options for the management of inflammatory bowel disease (IBD). With more than 10 years of experience behind us these agents have changed the natural history of the disease and have established themselves as a valid choice in the re...
Open access
Research Article
10.9734/BJMMR/2013/4691